Symbols / MURA
MURA Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-11-06 08:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- Mural Oncology (Nasdaq: MURA) scheme with XOMA unit effective as Nasdaq listing ends - Stock Titan Fri, 05 Dec 2025 08
- Mural Oncology (NASDAQ:MURA) Will Have To Spend Its Cash Wisely - simplywall.st ue, 05 Aug 2025 07
- Mural Oncology plc Announces Effective Date of Scheme Arrangement for Acquisition by XOMA Royalty Corporation - Quiver Quantitative Fri, 05 Dec 2025 08
- Stock Report: Can MURA grow without external funding - Weekly Trend Report & High Return Stock Watch Alerts - baoquankhu1.vn ue, 24 Feb 2026 19
- Lost Money in Rezolve AI (RZLV)? Investors Urged to Contact Award-Winning Firm, Gibbs Mura - Business Wire Mon, 15 Dec 2025 08
- Hub Group Accounting Error Leads to Plunging Stock Price - National Today Fri, 06 Feb 2026 08
- MURA’s Unexpected Surge: Analyzing Stock Movement - StocksToTrade Wed, 20 Aug 2025 07
- XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria Fri, 05 Dec 2025 08
- Insider Sale: Chief Financial Officer of $MURA Sells 7,148 Shares - Quiver Quantitative Mon, 10 Nov 2025 08
- Richtech Robotics Inc. Under Investigation After 20% Stock Drop - The AI Journal hu, 29 Jan 2026 08
- Failed Cancer Trial Forces Mural Oncology to Halt Development and Cut 90% of Workforce - Stock Titan ue, 15 Apr 2025 07
- Mura Emerges From Stealth with $6 Million in Seed Funding to Automate Commercial Field Service Operations with AI - Yahoo Finance ue, 20 May 2025 07
- Oakland Legal Sharks Circle Rezolve AI After Stock Nosedive - Hoodline ue, 16 Dec 2025 08
- Lawsuit Filed Against Stride, Inc. (LRN) After Shares Plummet Over 51% - Business Wire Wed, 12 Nov 2025 08
- Mural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57% - Clinical Trials Arena ue, 25 Mar 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MURA
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|